Cognitive FunctionNCT07564804
A Clinical Trial to Investigate the Efficacy of the Brain Blossom Supplement to Improve Cognitive Function and Memory
A study testing Dietary Supplement: Brain Blossom in people with Cognitive Function and Memory, run by Bio Nature Health at 1 site in United States.
Trial summary
This study evaluates the efficacy of BioNatureHealth's Brain Blossom supplement in improving cognitive function and memory in adults aged 50-70 years. Participants will be randomized to receive either the test product or placebo over 8 weeks, with cognitive battery testing and questionnaires administered at multiple… Read more about this study
- Who is it for?
- Ages 50 to 70 yearsHealthy volunteers can take part
- Conditions the study is for
- Cognitive Function, Memory, Cognitive Decline
- What is being tested?
- Dietary Supplement: Brain Blossom
- Type of treatment
- Pill or oral medicine
- Could I receive a placebo?
- Yes, some participants may receive a placebo
- How many people
- 60 participants
- Where
- 1 siteUnited States
- Study dates
- 28 Mar 2025to 27 Jun 2025
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 50 to 70 years
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- Male or female
- Aged 50-70 years
- Seeking to support cognitive function and memory
- Experiences at least three symptoms related to cognitive decline
- Willing to avoid new cognitive-related medications/supplements
- Generally healthy
Who cannot join
- Medical conditions affecting cognition
- Psychiatric or neurological disorders
- Diabetes or heart conditions
- Use of anticoagulants, benzodiazepines, or pain medications
- Substance abuse or heavy alcohol use
- Allergies to product ingredients
- Inability to comply with protocol
Trial locations and contacts
1 site in 1 country.
About this study
This study evaluates the efficacy of BioNatureHealth's Brain Blossom supplement in improving cognitive function and memory in adults aged 50-70 years. Participants will be randomized to receive either the test product or placebo over 8 weeks, with cognitive battery testing and questionnaires administered at multiple timepoints.
- Conditions
- Cognitive Function, Memory, Cognitive Decline
- Being tested
- Dietary Supplement: Brain Blossom, Placebo
- Keywords
- Brain health, Dietary supplement
- Medical subject headings
- Cognitive Dysfunction
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Dietary Supplement: Brain BlossomDietary supplement
Six capsules taken once daily in the morning with water.
PlaceboDietary supplement
Rice flour capsules
| Study group | Role | What they receive |
|---|---|---|
| Brain Blossom Supplement | Experimental | Participants receive the Brain Blossom supplement daily for 8 weeks. Receives: Dietary Supplement: Dietary Supplement: Brain Blossom |
| Placebo | Placebo comparator | Participants receive placebo capsules daily for 8 weeks. Receives: Dietary Supplement: Placebo |
What is being measured
The primary outcome is the main question the study is designed to answer.
Change in Cognitive Battery Composite Score
Cognitive function and memory will be assessed using a cognitive battery consisting of Polygons, Double Trouble, Feature Match, Paired Associates, Digit Span, and Spatial Planning tasks.
Measured: Baseline, Week 2, Week 4, Week 6, Week 8
Secondary outcomes (5)
Change in Self-Reported Memory and Recall
Assessed via study-specific questionnaires evaluating participants' perceived ability to retain and recall information.
Measured: Baseline, Week 2, Week 4, Week 6, Week 8
Change in Self-Reported Focus and Attentiveness
Measured using questionnaire items assessing the ability to concentrate and maintain attention.
Measured: Baseline, Week 2, Week 4, Week 6, Week 8
Change in Self-Reported Comprehension
Assessed via questionnaire responses evaluating participants' perceived ability to understand and process information.
Measured: Baseline, Week 2, Week 4, Week 6, Week 8
Change in Self-Reported Mental Clarity
Measured through questionnaire items assessing clarity of thought and mental sharpness.
Measured: Baseline, Week 2, Week 4, Week 6, Week 8
Change in Self-Reported Learning Acuity
Assessed via questionnaire responses evaluating participants' perceived ability to learn and retain new information.
Measured: Baseline, Week 2, Week 4, Week 6, Week 8
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted4 May 2026
- Study start28 Mar 2025
- Primary completion27 Jun 2025
- Study completion27 Jun 2025
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Cognitive FunctionStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Triple blind
- Who is masked
- Participant, Care provider, Outcomes assessor
- Enrolment
- 60 participants (actual)
Sponsor and investigators
- Lead sponsor
- Bio Nature Health
- Sponsor type
- Industry (pharma, biotech, devices)
- Collaborators
- Citruslabs
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07564804
- Sponsor's protocol ID
- 20737
- Status last verified
- Apr 2026
- First submitted
- 27 Apr 2026
- Last updated
- 4 May 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 4 May 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- A Clinical Trial to Investigate the Efficacy of the Brain Blossom Supplement to Improve Cognitive Function and Memory
- ClinicalTrials.gov ID
- NCT07564804
- Acronym / sponsor ID
- 20737
- Conditions
- Cognitive Function, Memory, Cognitive Decline
- Keywords
- Brain health, Dietary supplement
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 60 participants (actual)
- Lead sponsor
- Bio Nature HealthIndustry (pharma, biotech, devices)
- Collaborators
- Citruslabs
- Study start
- 28 Mar 2025 (actual)
- Primary completion
- 27 Jun 2025 (actual)
- Study completion
- 27 Jun 2025 (actual)
- First posted
- 4 May 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study evaluates the efficacy of BioNatureHealth's Brain Blossom supplement in improving cognitive function and memory in adults aged 50-70 years. Participants will be randomized to receive either the test product or placebo over 8 weeks, with cognitive battery testing and questionnaires administered at multiple timepoints.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Triple blind (participant, care provider, outcomes assessor)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Brain Blossom Supplement | Experimental | Dietary Supplement: Dietary Supplement: Brain BlossomParticipants receive the Brain Blossom supplement daily for 8 weeks. |
| Placebo | Placebo comparator | Dietary Supplement: PlaceboParticipants receive placebo capsules daily for 8 weeks. |
Who may qualify
- Ages
- 50 to 70 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (6 listed)
- Male or female
- Aged 50-70 years
- Seeking to support cognitive function and memory
- Experiences at least three symptoms related to cognitive decline
- Willing to avoid new cognitive-related medications/supplements
Key exclusion criteria (7 listed)
- Medical conditions affecting cognition
- Psychiatric or neurological disorders
- Diabetes or heart conditions
- Use of anticoagulants, benzodiazepines, or pain medications
- Substance abuse or heavy alcohol use
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Dietary Supplement: Brain BlossomSix capsules taken once daily in the morning with water. | Dietary supplement | Brain Blossom Supplement |
| PlaceboRice flour capsules | Dietary supplement | Placebo |
Primary outcome
Change in Cognitive Battery Composite Score
Time frame: Baseline, Week 2, Week 4, Week 6, Week 8
Cognitive function and memory will be assessed using a cognitive battery consisting of Polygons, Double Trouble, Feature Match, Paired Associates, Digit Span, and Spatial Planning tasks.
5 secondary outcomes
Change in Self-Reported Memory and Recall
Time frame: Baseline, Week 2, Week 4, Week 6, Week 8
Change in Self-Reported Focus and Attentiveness
Time frame: Baseline, Week 2, Week 4, Week 6, Week 8
Change in Self-Reported Comprehension
Time frame: Baseline, Week 2, Week 4, Week 6, Week 8
Change in Self-Reported Mental Clarity
Time frame: Baseline, Week 2, Week 4, Week 6, Week 8
Change in Self-Reported Learning Acuity
Time frame: Baseline, Week 2, Week 4, Week 6, Week 8
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 4 May 2026.
Related trials for Cognitive Function
Recruiting
Metabolic Health, Bones and Nuts During Weight Loss in Adults
Weight Loss, Bone Density
Not yet recruitingPhase 2
Lisdexamfetamine For the Treatment of Conduct Disorder in Children
Conduct Disorder
RecruitingPhase 4
Lidocaine Infiltration and Neuroimmunomodulation in Head and Neck Cancer Surgery
Head and Neck Cancer (H&N)
Recruiting
HEARS-NPS: Addressing Hearing Loss as a Common Unmet Contributor of Neuropsychiatric Symptoms
Alzheimer Disease, Dementia
RecruitingObservational study
Locus Coeruleus and CCHS (Congenital Central Hypoventilation Syndrome)
Ondine Syndrome (Congenital Central Hypoventilation Syndrome)
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Dietary Supplement: Brain Blossom in people with Cognitive Function and Memory, run by Bio Nature Health at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 6 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 4 May 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Change in Cognitive Battery Composite Score (time frame: Baseline, Week 2, Week 4, Week 6, Week 8). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 May 2026.